Newsbenzinga
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
· Published
Article summary
Xenetic Biosciences plans to acquire Santersus in an all-stock deal, forming Santersus Bio to tackle NET-driven diseases.
An excerpt from the original article.
Comments —
Loading comments…